Research Article
Investigation of Interleukin-27 in the Sera of Nonmelanoma Skin Cancer Patients
Table 1
Clinicopathologic characteristics of nonmelanoma skin cancer patients and their respective IL-27 serum levels in each subgroup.
| Variables | N( valid percent) | IL-27 serum level(ng/ml) | P-value1 |
| Gender | Male | 45(75.0%) | 0.00715 | 0.070 | Female | 15(25.0%) | 0.0989 |
| Pathology | SCC | 40(66.7%) | 0.01615 | 0.621 | BCC | 20(33.3%) | 0.00995 |
| Tumor Site | Sun-exposed | 54(93.10%) | 0.0134 | 0.091 | Not Sun-exposed | 4(6.90%) | 0.2812 |
| Multiple lesions | Yes | 8(16.67%) | 0.0589 | 0.778 | No | 40(83.33%) | 0.0134 |
|
|
|